Christopher Simon - 19 May 2022 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: President & CEO, Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Issuer symbol: HAE
Transactions as of: 19 May 2022
Net transactions value: -$147,514
Form type: 4
Filing time: 23 May 2022, 16:17:08 UTC
Previous filing: 18 May 2022
Next filing: 15 Jun 2022
SEC: View on sec.gov

Quoteable Key Fact

"Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 23 May 2022."

Quick Takeaways

This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 23 May 2022, 16:17.

What Changed

Previous filing in this sequence was filed on 18 May 2022.
Current net transaction value: -$147,514.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Sale	$147,514	-2,496	-1.1%	$59.10	214,872	19 May 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	This number includes unvested RSUs previously reported.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

This number includes unvested RSUs previously reported.